Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacy and Pharmacology|May 28, 2016
Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse modelKatrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, et al.
The Journal of Antimicrobial Chemotherapy|February 24, 2016
Drug permeation and barrier damage in Leishmania-infected mouse skinKatrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, et al.
Molecules (Basel, Switzerland)|September 5, 2020
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous LeishmaniasisAlaa Riezk, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous LeishmaniasisGert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Seminars in Immunopathology|March 11, 2020
Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugsPaul M Kaye, Israel Cruz, Albert Picado, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous LeishmaniasisGert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Pharmaceutics|April 30, 2021
Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous LeishmaniasisKatrien Van Bocxlaer, Kerri-Nicola McArthur, Andy Harris, et al.
Pageof 3